Speech-Language Pathologists in Mandan, ND Accepting Medicare
28 Speech-Language Pathologists found. Showing 21 - 28
 Rural Routes Therapies, Pllc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 404 Mia Ct Se, Mandan, ND 58554 Phone: 701-928-0964 |
 Melissa Mcconnell Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 901 Division St Nw, Mandan, ND 58554 Phone: 701-751-6500 |
Robyn Hennessy, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 309 Collins Ave, Mandan, ND 58554 Phone: 701-663-9531 Fax: 701-663-0328 |
Lindsey Schirado Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 901 Division St Nw, Mandan, ND 58554 Phone: 701-751-6500 |
Brianna Keller Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 901 Division St Nw, Mandan, ND 58554 Phone: 701-751-6500 |
Ashley Fischer Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 901 Division St Nw, Mandan, ND 58554 Phone: 701-751-6500 |
Arliss Koski Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 901 Division St Nw, Mandan, ND 58554 Phone: 701-751-6500 |
Kari Jo Stromstad, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 14th St Nw, Mandan, ND 58554 Phone: 701-663-7551 |
News Archive
Researchers replace organ in mice using 'single-parent' stem cells
Researchers at the University of Pennsylvania School of Veterinary Medicine have derived uniparental embryonic stem cells - created from a single donor's eggs or two sperm - and, for the first time, successfully used them to repopulate a damaged organ with healthy cells in adult mice.
Blast phase characteristics differ in TKI-, non-TKI–treated CML patients
Features of the blast phase, such as blast cell morphology and accompanying cytogenetic changes, vary between chronic myeloid leukaemia patients who received tyrosine kinase inhibitor therapy and those treated in the pre-TKI era, research shows.
Non-clinical data of CK-2017357 presented by Cytokinetics
Cytokinetics, Incorporated announced today that both a poster and an oral presentation summarizing non-clinical data regarding CK-2017357, a novel fast skeletal troponin activator, were presented at the 5th Cachexia Conference, organized by the Society on Cachexia and Wasting Disorders, being held December 5-8, 2009 in Barcelona, Spain.
More outreach needed for family members who carry genetic risks of cancer
A study done by researchers at Fox Chase Cancer Center shows that many relatives of patients who undergo testing for a gene linked to breast and ovarian cancers misinterpret the results, and less than half of those who could benefit from genetic testing say they plan to get tested themselves-despite the fact that knowing your genetic status may help catch the disease in its earliest stages.
New changes made to the Dose Conversion Guidelines on Fentanyl Transdermal Systems
The manufacturers of Fentanyl Transdermal Systems, in collaboration with Health Canada, would like to inform Canadians of important new changes made to the Dose Conversion Guidelines in the Product Monograph. These guidelines are used to help determine what dosage of Fentanyl Transdermal Systems is appropriate for each individual patient.
› Verified 9 days ago
- 1
- 2(current)
Speech-Language Pathologists
Chiropractors
Physical Therapists
Optometrists
Occupational Therapists